Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study-Reference-Cited by-同舟云学术

Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study

Published:2024-01 Issue:3 Volume:42 Page:535-540
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Muller M.P.,Navarro C.^ORCID,Wilson S.E.^ORCID,Shulha H.P.,Naus M.,Lim G.,Padhi S.,McGeer A.^ORCID,Finkelstein M.^ORCID,Liddy A.,Bettinger J.A.^ORCID

Funder

Canadian Institutes of Health Research

Public Health Agency of Canada

Publisher

Elsevier BV

Reference20 articles.

1. Prevention of monkeypox with vaccines: a rapid review;Poland;Lancet Infect Dis,2022

2. Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review;Elizaga;PLoS ONE [Electronic Resource],2013

3. Canada PHAo. Reporting adverse events following vaccination with Imvamune: Communique to healthcare professionals. Government of Canada. https://www.canada.ca/en/public-health/services/diseases/mpox/health-professionals/reporting-adverse-events-following-vaccination-imvamune-communique.html. Published 2022. Accessed 7/17/2023, 2023.

4. Monkeypox in Montreal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak;Harrison;Ann Intern Med,2023

5. A case of human monkeypox in Canada;Sukhdeo;CMAJ,2022

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccines against mpox: MVA-BN and LC16m8;Expert Review of Vaccines;2024-09

2. A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge;Vaccines;2024-07-26

3. Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc);Vaccines;2024-06-11